INIS
doses
93%
drugs
70%
brain
48%
administration
47%
comparative evaluations
38%
humans
36%
levels
34%
concentration
32%
dissolution
29%
populations
29%
symptoms
28%
reduction
26%
assessments
26%
safety
25%
surveys
23%
psychological behavior
23%
reviews
22%
control
20%
lysergic acid
18%
data
17%
performance
17%
pain
16%
patients
16%
interactions
15%
legal aspects
14%
intake
14%
utilities
14%
range
13%
alkaloids
13%
males
13%
Keyphrases
Psychedelics
100%
Psilocybin
53%
Ayahuasca
50%
Cannabis
50%
Healthy Volunteers
28%
Subjective Experience
21%
Altered States of Consciousness
20%
Cannabis Users
19%
4-fluoroamphetamine
19%
5-methoxy-N,N-dimethyltryptamine
19%
Placebo-controlled
19%
Well-being
18%
Ego Dissolution
18%
Ceremony
17%
Lysergic Acid Diethylamide
16%
Placebo-controlled Study
16%
Placebo
16%
Synthetic Cannabinoids
16%
Neurocognition
15%
JWH-018
14%
Microdosing
14%
Empathy
14%
Life Satisfaction
14%
Neuroadaptation
13%
Cannabis Use
13%
Creative Thinking
13%
Δ9-tetrahydrocannabinol (Δ9-THC)
13%
Glutamate
12%
Mental Health
12%
Functional Connectome
12%